273 related articles for article (PubMed ID: 17764778)
1. The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells.
von Haussen J; Koczulla R; Shaykhiev R; Herr C; Pinkenburg O; Reimer D; Wiewrodt R; Biesterfeld S; Aigner A; Czubayko F; Bals R
Lung Cancer; 2008 Jan; 59(1):12-23. PubMed ID: 17764778
[TBL] [Abstract][Full Text] [Related]
2. Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment.
Sainz B; Alcala S; Garcia E; Sanchez-Ripoll Y; Azevedo MM; Cioffi M; Tatari M; Miranda-Lorenzo I; Hidalgo M; Gomez-Lopez G; Cañamero M; Erkan M; Kleeff J; García-Silva S; Sancho P; Hermann PC; Heeschen C
Gut; 2015 Dec; 64(12):1921-35. PubMed ID: 25841238
[TBL] [Abstract][Full Text] [Related]
3. The antimicrobial peptide human cationic antimicrobial protein-18/cathelicidin LL-37 as a putative growth factor for malignant melanoma.
Kim JE; Kim HJ; Choi JM; Lee KH; Kim TY; Cho BK; Jung JY; Chung KY; Cho D; Park HJ
Br J Dermatol; 2010 Nov; 163(5):959-67. PubMed ID: 20977442
[TBL] [Abstract][Full Text] [Related]
4. Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer.
Weber G; Chamorro CI; Granath F; Liljegren A; Zreika S; Saidak Z; Sandstedt B; Rotstein S; Mentaverri R; Sánchez F; Pivarcsi A; Ståhle M
Breast Cancer Res; 2009; 11(1):R6. PubMed ID: 19183447
[TBL] [Abstract][Full Text] [Related]
5. Expression of the antimicrobial peptide cathelicidin in myeloid cells is required for lung tumor growth.
Li D; Beisswenger C; Herr C; Schmid RM; Gallo RL; Han G; Zakharkina T; Bals R
Oncogene; 2014 May; 33(21):2709-16. PubMed ID: 23812430
[TBL] [Abstract][Full Text] [Related]
6. Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections.
Jacobsen F; Mittler D; Hirsch T; Gerhards A; Lehnhardt M; Voss B; Steinau HU; Steinstraesser L
Gene Ther; 2005 Oct; 12(20):1494-502. PubMed ID: 15973442
[TBL] [Abstract][Full Text] [Related]
7. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18.
Koczulla R; von Degenfeld G; Kupatt C; Krötz F; Zahler S; Gloe T; Issbrücker K; Unterberger P; Zaiou M; Lebherz C; Karl A; Raake P; Pfosser A; Boekstegers P; Welsch U; Hiemstra PS; Vogelmeier C; Gallo RL; Clauss M; Bals R
J Clin Invest; 2003 Jun; 111(11):1665-72. PubMed ID: 12782669
[TBL] [Abstract][Full Text] [Related]
8. The human cathelicidin LL-37: a multifunctional peptide involved in infection and inflammation in the lung.
Tjabringa GS; Rabe KF; Hiemstra PS
Pulm Pharmacol Ther; 2005; 18(5):321-7. PubMed ID: 15939310
[TBL] [Abstract][Full Text] [Related]
9. Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling.
Ji P; Zhou Y; Yang Y; Wu J; Zhou H; Quan W; Sun J; Yao Y; Shang A; Gu C; Zeng B; Firrman J; Xiao W; Bals R; Sun Z; Li D
Theranostics; 2019; 9(8):2209-2223. PubMed ID: 31149039
[No Abstract] [Full Text] [Related]
10. Pulmonary defense and the human cathelicidin hCAP-18/LL-37.
Fahy RJ; Wewers MD
Immunol Res; 2005; 31(2):75-89. PubMed ID: 15778507
[TBL] [Abstract][Full Text] [Related]
11. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor.
Tjabringa GS; Aarbiou J; Ninaber DK; Drijfhout JW; Sørensen OE; Borregaard N; Rabe KF; Hiemstra PS
J Immunol; 2003 Dec; 171(12):6690-6. PubMed ID: 14662872
[TBL] [Abstract][Full Text] [Related]
12. The host defense peptide LL-37 activates the tumor-suppressing bone morphogenetic protein signaling via inhibition of proteasome in gastric cancer cells.
Wu WK; Sung JJ; To KF; Yu L; Li HT; Li ZJ; Chu KM; Yu J; Cho CH
J Cell Physiol; 2010 Apr; 223(1):178-86. PubMed ID: 20054823
[TBL] [Abstract][Full Text] [Related]
13. Expression of LL-37/hCAP-18 gene in human leukemia cells.
Yang YH; Zheng GG; Li G; Zhang B; Song YH; Wu KF
Leuk Res; 2003 Oct; 27(10):947-50. PubMed ID: 12860015
[TBL] [Abstract][Full Text] [Related]
14. Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion.
Coffelt SB; Waterman RS; Florez L; Höner zu Bentrup K; Zwezdaryk KJ; Tomchuck SL; LaMarca HL; Danka ES; Morris CA; Scandurro AB
Int J Cancer; 2008 Mar; 122(5):1030-9. PubMed ID: 17960624
[TBL] [Abstract][Full Text] [Related]
15. Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells.
Coffelt SB; Tomchuck SL; Zwezdaryk KJ; Danka ES; Scandurro AB
Mol Cancer Res; 2009 Jun; 7(6):907-15. PubMed ID: 19491199
[TBL] [Abstract][Full Text] [Related]
16. MUC2 Mucin and Butyrate Contribute to the Synthesis of the Antimicrobial Peptide Cathelicidin in Response to Entamoeba histolytica- and Dextran Sodium Sulfate-Induced Colitis.
Cobo ER; Kissoon-Singh V; Moreau F; Holani R; Chadee K
Infect Immun; 2017 Mar; 85(3):. PubMed ID: 28069814
[TBL] [Abstract][Full Text] [Related]
17. Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37.
Tokumaru S; Sayama K; Shirakata Y; Komatsuzawa H; Ouhara K; Hanakawa Y; Yahata Y; Dai X; Tohyama M; Nagai H; Yang L; Higashiyama S; Yoshimura A; Sugai M; Hashimoto K
J Immunol; 2005 Oct; 175(7):4662-8. PubMed ID: 16177113
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37.
Carretero M; Escámez MJ; García M; Duarte B; Holguín A; Retamosa L; Jorcano JL; Río MD; Larcher F
J Invest Dermatol; 2008 Jan; 128(1):223-36. PubMed ID: 17805349
[TBL] [Abstract][Full Text] [Related]
19. Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure.
Shaykhiev R; Beisswenger C; Kändler K; Senske J; Püchner A; Damm T; Behr J; Bals R
Am J Physiol Lung Cell Mol Physiol; 2005 Nov; 289(5):L842-8. PubMed ID: 15964896
[TBL] [Abstract][Full Text] [Related]
20. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface.
Bals R; Wang X; Zasloff M; Wilson JM
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9541-6. PubMed ID: 9689116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
